National Institutes of Health Pathways to Prevention Workshop: Research Gaps for Long-Term Drug Therapies for Osteoporotic Fracture Prevention. [electronic resource]
- Annals of internal medicine 07 2019
- 51-57 p. digital
Publication Type: Consensus Development Conference, NIH; Journal Article
1539-3704
10.7326/M19-0961 doi
Biomedical Research Bone Density Conservation Agents--adverse effects Decision Making, Shared Denosumab--adverse effects Diphosphonates--adverse effects Duration of Therapy Evidence-Based Medicine Female Humans National Institutes of Health (U.S.) Osteoporotic Fractures--prevention & control Patient Acceptance of Health Care Risk Assessment United States